Analysen zu BioNTech (ADRs)
| 03.10.24 | BioNTech Buy | Deutsche Bank AG | |
| 02.10.24 | BioNTech Neutral | UBS AG | |
| 19.09.24 | BioNTech Buy | Deutsche Bank AG | |
| 18.09.24 | BioNTech Neutral | UBS AG | |
| 17.09.24 | BioNTech Buy | Jefferies & Company Inc. | |
| 16.09.24 | BioNTech Neutral | JP Morgan Chase & Co. | |
| 13.09.24 | BioNTech Hold | Jefferies & Company Inc. | |
| 09.09.24 | BioNTech Underweight | JP Morgan Chase & Co. | |
| 16.08.24 | BioNTech Hold | Jefferies & Company Inc. | |
| 16.08.24 | BioNTech Underweight | JP Morgan Chase & Co. | |
| 06.08.24 | BioNTech Neutral | Goldman Sachs Group Inc. | |
| 05.08.24 | BioNTech Hold | Jefferies & Company Inc. | |
| 24.05.24 | BioNTech Hold | Deutsche Bank AG | |
| 10.05.24 | BioNTech Neutral | UBS AG | |
| 08.05.24 | BioNTech Hold | Deutsche Bank AG | |
| 07.05.24 | BioNTech Neutral | Goldman Sachs Group Inc. | |
| 06.05.24 | BioNTech Hold | Jefferies & Company Inc. | |
| 23.04.24 | BioNTech Hold | Deutsche Bank AG | |
| 22.03.24 | BioNTech Hold | Deutsche Bank AG | |
| 21.03.24 | BioNTech Hold | Deutsche Bank AG | |
| 21.03.24 | BioNTech Neutral | Goldman Sachs Group Inc. | |
| 20.03.24 | BioNTech Hold | Jefferies & Company Inc. | |
| 20.03.24 | BioNTech Neutral | UBS AG |
Aktuelle Aktienanalysen
| 16.01.26 | Sanofi Buy | Deutsche Bank AG | |
| 16.01.26 | Diageo Outperform | Bernstein Research | |
| 16.01.26 | Roche Hold | Deutsche Bank AG | |
| 16.01.26 | Novo Nordisk Buy | Deutsche Bank AG | |
| 16.01.26 | GSK Hold | Deutsche Bank AG | |
| 16.01.26 | AstraZeneca Buy | UBS AG | |
| 16.01.26 | Novartis Buy | Deutsche Bank AG | |
| 16.01.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 16.01.26 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.01.26 | London Stock Exchange Buy | Jefferies & Company Inc. | |
| 16.01.26 | Deutsche Börse Hold | Jefferies & Company Inc. | |
| 16.01.26 | JOST Werke Buy | Warburg Research | |
| 16.01.26 | freenet Equal Weight | Barclays Capital | |
| 16.01.26 | Deutsche Telekom Overweight | Barclays Capital | |
| 16.01.26 | Vodafone Group Overweight | Barclays Capital | |
| 16.01.26 | 1&1 Equal Weight | Barclays Capital | |
| 16.01.26 | ASML NV Outperform | Bernstein Research | |
| 16.01.26 | Schoeller-Bleckmann accumulate | Erste Group Bank | |
| 16.01.26 | Grand City Properties Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.01.26 | Shell Overweight | Barclays Capital | |
| 16.01.26 | Klöckner Sell | Warburg Research | |
| 16.01.26 | Fraport Hold | Jefferies & Company Inc. | |
| 16.01.26 | adidas Buy | UBS AG | |
| 16.01.26 | Richemont Overweight | Barclays Capital | |
| 16.01.26 | Münchener Rückversicherungs-Gesellschaft Overweight | Barclays Capital | |
| 16.01.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 16.01.26 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.01.26 | BP Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.01.26 | Richemont Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.01.26 | Jungheinrich Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.01.26 | AXA Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.01.26 | Merck Overweight | JP Morgan Chase & Co. | |
| 16.01.26 | Pernod Ricard Neutral | JP Morgan Chase & Co. | |
| 16.01.26 | Henkel vz. Underweight | JP Morgan Chase & Co. | |
| 16.01.26 | AB InBev Overweight | JP Morgan Chase & Co. | |
| 16.01.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 16.01.26 | Danone Overweight | JP Morgan Chase & Co. | |
| 16.01.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 16.01.26 | Beiersdorf Overweight | JP Morgan Chase & Co. | |
| 16.01.26 | L'Oréal Neutral | JP Morgan Chase & Co. | |
| 16.01.26 | JCDecaux Neutral | JP Morgan Chase & Co. | |
| 16.01.26 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 16.01.26 | Stellantis Overweight | JP Morgan Chase & Co. | |
| 16.01.26 | Givaudan Overweight | Barclays Capital | |
| 16.01.26 | Akzo Nobel Overweight | Barclays Capital | |
| 16.01.26 | Air Liquide Overweight | Barclays Capital | |
| 16.01.26 | Symrise Equal Weight | Barclays Capital | |
| 16.01.26 | WACKER CHEMIE Equal Weight | Barclays Capital | |
| 16.01.26 | Evonik Equal Weight | Barclays Capital | |
| 16.01.26 | BASF Equal Weight | Barclays Capital |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.